Hypomyelinating disorders: An MRI approach

Neurobiology of Disease

Volumn 87, Issue , 2016, Pages 50-58

  Barkovich, A James ^a   Deon, Sean ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dysmyelinating and demyelinating disorders; Genetic leukoencephalopathies; Hypomyelinating disorders

Indexed keywords

CLINICAL FEATURE; DEMYELINATING DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC DISORDER; HUMAN; HYPOMYELINATING DISORDER; IMAGING SYSTEM; INBORN ERROR OF METABOLISM; LEUKODYSTROPHY; LEUKOENCEPHALOPATHY; MYELIN WATER FRACTION IMAGING; MYELINATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SYSTEMIC DISEASE; WHITE MATTER; ANIMAL; BRAIN; METABOLISM; MYELIN SHEATH; PATHOLOGY; PROCEDURES;

ANIMALS; BRAIN; DEMYELINATING DISEASES; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MYELIN SHEATH;

EID: 84951083885     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.10.015     Document Type: Review

References (111)

1. Barker P.B. Fundamentals of MR spectroscopy. Clinical MR Imaging 2010, 5-20. Cambridge, New York. 2nd ed. J.H. Gillard, A.D. Waldman, P.B. Barker (Eds.).
2. Barkovich A.J. Concepts of myelin and myelination in neuroradiology. AJNR Am. J. Neuroradiol. 2000, 21(6):1099-1109.
3. Barkovich A.J., Kjos B.O., Jackson D.E., Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5T. Radiology 1988, 166:173-180.
4. Benarroch E.E. N-acetylaspartate and N-acetylaspartylglutamate. Neurobiology and clinical significance. Neurology 2008, 70:1353-1357.
5. Bernard G., Vanderver A. Pol III-related leukodystrophies. Gene Rev. 2012, (http://www.ncbi.nlm.nih.gov/pubmed/22855961).
6. Biancheri R., Zara F., Bruno C., et al. Phenotypic characterization of hypomyelination and congenital cataract. Ann. Neurol. 2007, 62:121-127.
7. Biancheri R., Zara F., Rossi A., et al. Hypomyelination and congenital cataract: broadening the clinical phenotype. Arch. Neurol. 2011, 68(9):1191-1194.
8. Biancheri R., Rosano C., Denegri L., et al. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. Eur. J. Hum. Genet. 2013, 21:34-39.
9. Bjarnson T.A., Vavasour I.M., Chia C.L.L., MacKay A.L. Characterization of the NMR behaviour of white matter in bovine brain. Magn. Reson. Med. 2005, 54:1072-1081.
10. Blezer E.L.A., Bauer J., Brok H.P.M., Nicolay K. t Hart BA. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed. 2007, 20(2):90-103.
11. Boespflug-tanguy O. Chapter 162 - inborn errors of brain myelin formation. Handbook of Clinical Neurology 2013, vol. 113:1581-1592. Elsevier. M.L. Olivier Dulac, B.S. Harvey (Eds.).
12. Daoud H., Tétreault M., Gibson W., et al. Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. J. Med. Genet. 2013, 50(3):194-197. (March 1, 2013).
13. De Bock M., Kerrebrouck M., Wang N., Leybaert L. Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system?. Front. Pharmacol. 2013, 4.
14. Deoni S.C.L., Kolind S.H. Investigating the stability of mcDESPOT myelin water fraction values derived using a stochastic region contraction approach. Magn. Reson. Med. 2015, 73(1):161-169.
15. Dhaunchak A.S., Colman D.R., Nave K.-A. Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease. J. Neurosci 2011, 31(42):14961-14971.
16. Dietrich R.B., Bradley W.G., Zagaroza E.J., et al. MR evaluation of early myelination patterns in normal and developmentally delayed infants. AJNR Am. J. Neuroradiol. 1988, 9:69-76.
17. Dreha-Kulaczewski S.F., Brockmann K., Henneke M., et al. Assessment of myelination in hypomyelinating disorders by quantitative MRI. J. Magn. Reson. Imaging 2012, (n/a-n/a).
18. Dubois J., Hertz-Pannier L., Dehaene-Lambertz G., Cointepas Y., Le Bihan D. Assessment of the early organization and maturation of infants' cerebral white matter fiber bundles: a feasibility study using quantitative diffusion tensor imaging and tractography. NeuroImage 2006, 30:1121-1132.
19. Dubois J., Dehaene-Lambertz G., Kulikova S., Poupon C., Hüppi P.S., Hertz-Pannier L. The early development of brain white matter: a review of imaging studies in fetuses, newborns and infants. Neuroscience 2014, 276:48-71.
20. Dula A.N., Gochberg D.F., Valentine H.L., Valentine W.M., Does M.D. Multiexponential T2, magnetization transfer, and quantitative histology in white matter tracts of rat spinal cord. Magn. Reson. Med. 2010, 63(4):902-909.
21. Ernst T. Quantification and analysis in MR spectroscopy. Clinical MR Imaging 2010, 21-29. Cambridge, New York. 2nd ed. J.H. Gillard, A.D. Waldman, P.B. Barker (Eds.).
22. Etienne-Manneville S. Microtubules in cell migration. Annu. Rev. Cell Dev. Biol. 2013, 29:471-499.
23. Faghri S., Tamura D., Kraemer K.H., DiGiovanna J.J. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J. Med. Genet. 2008, 45(10):609-621. (October 1, 2008).
24. Flechsig P. Anatomie des menschlichen Gehirns und Ruchenmarks auf myelogenetischer Grundlage 1920, Georg Thieme, Leipzig.
25. Franker M.A.M., Hoogenraad C.C. Microtubule-based transport - basic mechanisms, traffic rules and role in neurological pathogenesis. J. Cell Sci. 2013, 126(11):2319-2329. (June 1, 2013).
26. Garbern J.Y., Cambi F., Lewis R., et al. Peripheral neuropathy caused by proteolipid protein gene mutations. Ann. N. Y. Acad. Sci. 1999, 883(1):351-365.
27. Gareau P.J., Rutt B.K., Karlik S.J., Mitchell J.R. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J. Magn. Reson. Imaging 2000, 11(6):586-595.
28. Giglia-Mari G., Coin F., Ranish J.A., et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat. Genet. 2004, 36(7):714-719. (07//print).
29. Gotoh L., Inoue K., Helman G., et al. GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease. Mol. Genet. Metab. 2014, 111(3):393-398. (3//).
30. Graham S.J., Henkelman R.M. Pulsed magnetization transfer imaging: evaluation of technique. Radiology 1999, 212(3):903-910. (1999/09/01).
31. Gupta N., Henry R.G., Strober J., et al. Neural stem cell engraftment and myelination in the human brain. Sci. Transl. Med. 2012, 4(155):155ra137. (October 10, 2012).
32. Gutmann D., Zackai E., McDonald-McGinn D., Fischbeck K., Kamholz J. Oculodentodigital dysplasia syndrome associated with abnormal cerebral white matter. Am. J. Med. Genet. 1991, 41:18-20.
33. Gv B., Chouery E., Putorti M.L., et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am. J. Hum. Genet. 2011, 89(3):415-423.
34. Hamilton E.M., Polder E., Vanderver A., et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation. Brain 2014, 137(7):1921-1930.
35. Hanefeld F.A., Brockmann K., Pouwels P.J.W., Wilken B., Frahm J., Dechent P. Quantitative proton MRS of Pelizaeus-Merzbacher disease. Evidence of dys- and hypomyelination. Neurology 2005, 65:701-706.
36. Harreld J.H., Smith E.C., Prose N.S., Puri P.K., Barboriak D.P. Trichothiodystrophy with dysmyelination and central osteosclerosis. AJNR Am. J. Neuroradiol. 2010, 31:129-130.
37. Harsan L.A., Poulet P., Guignard B., et al. Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J. Neurosci. Res. 2006, 83(3):392-402.
38. Hashimoto S., Egly J.M. Trichothiodystrophy view from the molecular basis of DNA repair/transcription factor TFIIH. Hum. Mol. Genet. 2009, 18(R2):R224-R230. (October 15, 2009).
39. Henkelman R.M., Stanisz G.J., Graham S.J. Magnetization transfer in MRI: a review. NMR Biomed. 2001, 14(2):57-64.
40. Hoeijmakers J.H.J. Human nucleotide excision repair syndromes: molecular clues to unexpected intricacies. Cancer 1994, 30A:1912-1924.
41. Holland B.A., Haas D.K., Norman D., Brant-Zawadzki M., Newton T.H. MRI of normal brain maturation. Am. J. Neuroradiol. 1986, 7:201-208.
42. Hüppi P., Maier S., Peled S., et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr. Res. 1998, 44:584-590.
43. Jensen J.H., Helpern J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010, 23(7):698-710.
44. J-i T., Nitta N., Iwasaki N., et al. Neurochemistry in shiverer mouse depicted on MR spectroscopy. J. Magn. Reson. Imaging 2013, (n/a-n/a).
45. Jones D.K., Knösche T.R., Turner R. White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. NeuroImage 2013, 73(0):239-254. (6//).
46. Kevelam S.H., Taube J.R., van Spaendonk R.M.L., et al. Altered PLP1 splicing causes hypomyelination of early myelinating structures. Ann. Clin. Transl. Neurol. 2015, 2(6):648-661.
47. Kinney H.C., Brody B.A., Kloman A.S., Gilles F.H. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J. Neuropathol. Exp. Neurol. 1988, 47:217-234.
48. Koeppen A.H., Ronca N.A., Greenfield E., Hans M.B. Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacher disease. Ann. Neurol. 1987, 21:159-170.
49. La Piana R., Tonduti D., Dressman H.G., et al. Brain magnetic resonance imaging (MRI) pattern recognition in Pol III-related leukodystrophies. J. Child Neurol. 2014, 29(2):214-220. February 1, 2014.
50. Labadie C., Lee J.-H., Rooney W.D., et al. Myelin water mapping by spatially regularized longitudinal relaxographic imaging at high magnetic fields. Magn. Reson. Med. 2014, 71(1):375-387.
51. Lankford C.L., Does M.D. On the inherent precision of mcDESPOT. Magn. Reson. Med. 2013, 69(1):127-136. 03/12.
52. Levesque I.R., Pike G.B. Characterizing healthy and diseased white matter using quantitative magnetization transfer and multicomponent T2 relaxometry: a unified view via a four-pool model. Magn. Reson. Med. 2009, 62(6):1487-1496.
53. LeVine S.M., Wong D., Macklin W.B. Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain. Dev. Neurosci. 1990, 12(4-5):235-250.
54. Linnankivi T., Tienari P., Somer M., et al. 18q deletions: clinical, molecular, and brain MRI findings of 14 individuals. Am. J. Med. Genet. A 2006, 140A(4):331-339.
55. Mackay A., Whittall K., Adler J., Li D., Paty D., Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med. 1994, 31(6):673-677.
56. MacKay A., Laule C., Vavasour I., Bjarnason T., Kolind S., Mädler B. Insights into brain microstructure from the T2 distribution. Magn. Reson. Imaging 2006, 24(4):515-525. (5//).
57. Menichella D.M., Goodenough D.A., Sirkowski E., Scherer S.S., Paul D.L. Connexins are critical for normal myelination in the CNS. J. Neurosci. 2003, 23(13):5963-5973. (July 2, 2003).
58. Menon R.S., Rusinko M.S., Allen P.S. Multiexponential proton relaxation in model cellular systems. Magn. Reson. Med. 1991, 20(2):196-213.
59. Meyer E., Kurian M.A., Morgan N.V., et al. Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like disease. Mol. Genet. Metab. 2011, 104(4):637-643.
60. Norton K., Carey J.C., Gutmann D.H. Oculodentodigital dysplasia with cerebral white matter abnormalities in a two-generation family. Am. J. Med. Genet. 1995, 57:458-461.
61. Nossin-Manor R., Chung A.D., Whyte H.E.A., Shroff M.M., Taylor M.J., Sled J.G. Deep gray matter maturation in very preterm neonates: regional variations and pathology-related age-dependent changes in magnetization transfer ratio. Radiology 2012, 263(2):510-517. (2012/05/01).
62. Nossin-Manor R., Card D., Morris D., et al. Quantitative MRI in the very preterm brain: assessing tissue organization and myelination using magnetization transfer, diffusion tensor and T1 imaging. NeuroImage 2013, 64(0):505-516. (1/1/).
63. Numata Y., Morimura T., Nakamura S., et al. Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the Golgi apparatus associated with pathogenesis in Pelizaeus-Merzbacher disease. J. Biol. Chem. 2013, 288(11)):7451-7466. March 15, 2013.
64. Odrobina E.E., Lam T.Y.J., Pun T., Midha R., Stanisz G.J. MR properties of excised neural tissue following experimentally induced demyelination. NMR Biomed. 2005, 18(5):277-284.
65. Ostergaard J.R., Christensen T. The central nervous system in Tay syndrome. Neuropediatrics 1996, 27:326-330.
66. Østergaard J.R., Christensen T. The central nervous system in Tay syndrome. Neuropediatrics 1996, 27:326-330.
67. Paus T., Collins D.L., Evans A.C., Leonard G., Pike B., Zijdenbos A. Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res. Bull. 2001, 54(3):255-266. (2//).
68. Paznekas W.A., Karczeski B., Vermeer S., et al. GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum. Mutat. 2009, 30(5):724-733.
69. Pierpaoli C., Basser P.J. Toward a quantitative assessment of diffusion anisotropy. Magn. Reson. Med. 1996, 36(6):893-906.
70. Pizzino A., Pierson T.M., Guo Y., et al. TUBB4A de novo mutations cause isolated hypomyelination. Neurology 2014, 83(10):898-902. (02/07/received 06/02/accepted).
71. Porto L., Weis R., Schulz C., Reichel P., Lanfermann H., Zanella F.E. Tay's syndrome: MRI. Neuroradiology 2000, 42:849-851.
72. Pouwels P.J.W., Vanderver A., Bernard G., et al. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann. Neurol. 2014, 76(1):5-19.
73. Prayer D., Barkovich A.J., Kirschner D.A., et al. Visualization of nonstructural changes in early white matter development on diffusion weighted MR images: evidence supporting premyelination anisotropy. AJNR Am. J. Neuroradiol. 2001, 22:1572-1576.
74. Ruest T., Holmes W.M., Barrie J.A., et al. High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology. NMR Biomed. 2011, 24:1369-1379.
75. Sakakibara A., Ando R., Sapir T., Tanaka T. Microtubule dynamics in neuronal morphogenesis. Open Biol. 2013, 3(7).
76. Schiffmann R., van der Knaap M.S. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009, 72(8):750-759.
77. Schiffmann R., Moller J.R., Trapp B.D., et al. Childhood ataxia with diffuse central nervous system hypomyelination. Ann. Neurol. 1994, 35:331-340.
78. Schmierer K., Tozer D.J., Scaravilli F., et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J. Magn. Reson. Imaging 2007, 26(1):41-51.
79. Simons C., Wolf Nicole I., McNeil N., et al. A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am. J. Hum. Genet. 2013, (0).
80. Sistermans E.A., de Coo rFM., De Wijs I.J., Van Oost B.A. Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 1998, 50:1749-1754.
81. Sled J.G., Pike G.B. Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn. Reson. Med. 2001, 46(5):923-931.
82. Song S.-K., Sun S.-W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage 2002, 17(3):1429.
83. Southwood C.M., Garbern J.Y., Jiang W., Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002, 36(4):585-596.
84. Stanisz G.J., Kecojevic A., Bronskill M.J., Henkelman R.M. Characterizing white matter with magnetization transfer and T2. Magn. Reson. Med. 1999, 42(6):1128-1136.
85. Steenweg M., Vanderver A., Blaser S., et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 2010, 133:2971-2982.
86. Tada H., Takanashi J.-i. MR spectroscopy in 18q-syndrome suggesting other than hypomyelination. Brain Dev. 2014, 36(1):57-60. (1//).
87. Taft R., Vanderver A., Leventer Richard J., et al. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am. J. Hum. Genet. 2013, 92(5):774-780.
88. Takanashi J., Inoue K., Tomita M., et al. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication. Neurology 2002, 58:237-241.
89. Takanashi J., Saito S., Aoki I., Barkovich A.J., Ito Y., Inoue K. Increased N-acetylaspartate in mouse model of Pelizaeus-Merzbacher disease. J. Magn. Reson. Imaging 2012, 35:418-425.
90. Tanaka R., Iwasaki N., Hayashi M., et al. Abnormal brain MRI signal in 18q-syndrome not due to dysmyelination. Brain Dev. 2012, 34(3):234-237.
91. Traverso M., Assereto S., Gazzerro E., et al. Novel FAM126A mutations in hypomyelination and congenital cataract disease. Biochem. Biophys. Res. Commun. 2013, 439(3):369-372. (9/27/).
92. Uchida N., Chen K., Dohse M., et al. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci. Transl. Med. 2012, 4(155):155ra136. (October 10, 2012).
93. Ugur S.A., Tolun A. A deletion in DRCTNNB1A associated with hypomyelination and juvenile onset cataract. Eur. J. Hum. Genet. 2008, 16:261-264.
94. Uhlenberg B., Schuelke M., Rüschendorf F., et al. Mutations in the gene encoding gap junction protein alpha-12 (Connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am. J. Hum. Genet. 2004, 75(2):251-260.
95. van der Knaap M.S., Valk J. Pelizaeus Merzbacher disease and X-linked spastic paraplegia type 2. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders 2005, 272-280. Springer, Berlin. 3rd ed. M.S. van der Knaap, J. Valk (Eds.).
96. van der Knaap M.S., Valk J. 18q-syndrome. Magnetic Resonance of Myelination and Myelin Disorders 2005, 281-283. Springer, Berlin. 3rd ed. M.S. van der Knaap, J. Valk (Eds.).
97. van der Knaap M.S., Valk J. Magnetic Resonance of Myelination and Myelin Disorders, 3rd Edition 2005, Springer, Berlin. 3rd ed.
98. van der Knaap M., Linnankivi T., Paetau A., et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology 2007, 69:166-171.
99. Vasung L., Fischi-Gomez E., Hüppi P. Multimodality evaluation of the pediatric brain: DTI and its competitors. Pediatr. Radiol. 2013, 43(1):60-68. (2013/01/01).
100. Walczak C.E., Gayek S., Ohi R. Microtubule-depolymerizing kinesins. Annu. Rev. Cell Dev. Biol. 2013, 29(1):417-441. (2013/10/06).
101. Weeda G., Eveno E., Donker I., et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am. J. Hum. Genet. 1997, 60:320-329.
102. Whittall K.P., MacKay A.L., Graeb D.A., Nugent R.A., Li D.K., Paty D.W. In vivo measurement of T2 distributions and water contents in normal human brain. Magn. Reson. Med. 1997, 40:34-43.
103. Wilhelm M.J., Ong H.H., Wehrli S.L., et al. Direct magnetic resonance detection of myelin and prospects for quantitative imaging of myelin density. Proc. Natl. Acad. Sci. 2012, 109(24):9605-9610. (June 12, 2012).
104. Wimberger D.M., Roberts T.P., Barkovich A.J., Prayer L.M., Moseley M.E., Kucharczyk J. Identification of "premyelination" by diffusion-weighted MRI. J. Comput. Assist. Tomogr. 1995, 19:28-33.
105. Wolf N.I., Harting I., Boltshauser E., et al. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology 2005, 64(8):1461-1464.
106. Wolf N.I., Harting I., Innes A.M., et al. Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy. Neuropediatrics 2007, 38(2):64-70.
107. Wolf N.I., Salomons G.S., Rodenburg R.J., et al. Mutations in RARS cause hypomyelination. Ann. Neurol. 2014, 76(1):134-139.
108. Wolfe C.L., Warrington J.A., Treadwell L., Norcum M.T. A three-dimensional working model of the multienzyme complex of aminoacyl-tRNA synthetases based on electron microscopic placements of tRNA and proteins. J. Biol. Chem. 2005, 280(46):38870-38878. (November 18, 2005).
109. Wolff S.D., Balaban R.S. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn. Reson. Med. 1989, 11:135-144.
110. Yakovlev P.I., Lecours A.R. The myelogenetic cycles of regional maturation of the brain. Regional Development of the Brain in Early Life 1967, 3-70. Blackwell, Oxford. A. Minkowski (Ed.).
111. Zara F., Biancheri R., Bruno C., et al. Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract. Nat. Genet. 2006, 38(10):1111-1113.